Drusen volume as a study endpoint

Ophthalmology

Volumn 119, Issue 7, 2012, Pages 1501-1502

  Maguire, Maureen G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; VITAMIN; ZINC;

CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DISEASE MARKER; DRUSEN; HUMAN; LETTER; LOW LEVEL LASER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY;

FEMALE; HUMANS; MACULAR DEGENERATION; MALE; RETINAL DRUSEN; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84863315089     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.03.012     Document Type: Letter

References (4)

1. Z. Yehoshua, F. Wang, P.J. Rosenfeld Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography Ophthalmology 118 2011 2434 2441
2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use E9. ICH Harmonised tripartite guideline: statistical principles for clinical trials 1998 European Medicines Agency London 7
3. Complications of Age-related Macular Degeneration Prevention Trial Research Group Laser treatment in patients with bilateral large drusen: The Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Ophthalmology 113 2006 1974 1986
4. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 Arch Ophthalmol 119 2001 1417 1436